Publications by authors named "Jacob Stroh"

Claim this Profile
T
Tixagevimab/Cilgavimab for COVID-19 Pre-Exposure Prophylaxis in Hematologic Patients-A Tailored Approach Based on SARS-CoV-2 Vaccine Response.
Krischan Braitsch, Samuel D Jeske, Jacob Stroh, Maike Hefter, Louise Platen

Vaccines (Basel)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Actionable loss of SLF2 drives B-cell lymphomagenesis and impairs the DNA damage response.
Le Zhang, Matthias Wirth, Upayan Patra, Jacob Stroh, Konstandina Isaakidis

EMBO Mol Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma.
Jacob Stroh, Anja Seckinger, Michael Heider, Martina Rudelius, Ruth Eichner

Blood Adv· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial evaluation of [F]-FACBC for PET imaging of multiple myeloma.
Volker Morath, Michael Heider, Markus Mittelhäuser, Hannes Rolbieski, Jacob Stroh

EJNMMI Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The IMiD target CRBN determines HSP90 activity toward transmembrane proteins essential in multiple myeloma.
Michael Heider, Ruth Eichner, Jacob Stroh, Volker Morath, Anna Kuisl

Mol Cell· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis